AbbVie Inc at TD Cowen Health Care Conference Transcript

Mar 05, 2024 / 02:10PM GMT
Stephen Michael Scala - TD Cowen, Research Division - MD & Senior Research Analyst

Okay. So. Thank you and good morning. Thanks for (inaudible). We're delighted to have AbbVie at 44th Annual Healthcare Conference and representing the company, we have a number of members of management. Rob Michael, who is President and COO; and of course, incoming CEO; Jeff Stewart, who is Executive Vice President and Chief Commercial Officer; and Roopal Thakkar, who is Senior Vice President Chief Medical Officer of Global Therapeutics. Also here is Scott Reents, who is Executive Vice President and CFO. So thank you so much for making the journey lots to talk about at AbbVie. There's always great stuff going on.

But let's start out with kind of a big picture, Rob -- a question, Rob. So as the incoming CEO, what should investors expect relative to changes at AbbVie, if any?

Questions and Answers:

Robert A. Michael - AbbVie Inc. - President & COO

Well, Steve, as you know, I've been with AbbVie since our inception. So my goal is to make it as seamless as
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot